Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical, Inc. (GMED) Q1 2023 Earnings Call Transcript
11:00pm, Thursday, 04'th May 2023
Globus Medical, Inc. (NYSE:GMED ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations Dan S
Globus Medical (GMED) Surpasses Q1 Earnings and Revenue Estimates
08:30pm, Thursday, 04'th May 2023
Globus Medical (GMED) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.42 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff
05:41am, Thursday, 04'th May 2023
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
Globus Medical Schedules First Quarter Earnings Release and Conference Call
05:15pm, Wednesday, 19'th Apr 2023
AUDUBON, Pa., April 19, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31
7 Stocks to Buy with Bulletproof Balance Sheets
07:22pm, Monday, 17'th Apr 2023
With a recession possibly on the horizon, investors may want to consider acquiring stocks with strong balance sheets. Of course, the underlying topic features much debate.
Globus' (GMED) NUVA Buyout Seems Strategic, Cost Woe Stays
12:09pm, Friday, 14'th Apr 2023
Globus Medical (GMED) and NuVasive (NUVA) are currently planning to combine in an all-stock transaction to create a global musculoskeletal company.
Globus Medical (GMED) to Gain From NUVA Deal Amid Rising Costs
12:13pm, Friday, 24'th Mar 2023
The NuVasive acquisition aims to outpace market growth by combining Globus Medical's (GMED) engineering and NuVasive's relations, education and training.
Globus Medical (GMED) Q4 Earnings Beat, Operating Margin Rises
09:47am, Wednesday, 22'nd Feb 2023
Globus Medical (GMED) reports strong fourth-quarter sales growth amid currency headwinds and lingering COVID-19 impacts.
Globus Medical, Inc. (GMED) Q4 2022 Earnings Call Transcript
08:05pm, Tuesday, 21'st Feb 2023
Globus Medical, Inc. (NYSE:GMED ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Kearns - Senior Vice President of Business Development and Investor Relations
Globus Medical (GMED) Tops Q4 Earnings Estimates
06:49pm, Tuesday, 21'st Feb 2023
Globus Medical (GMED) delivered earnings and revenue surprises of 7.27% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Top 5 Health Care Stocks That Could Blast Off This Month - Azenta (NASDAQ:AZTA), Amgen (NASDAQ:AMGN)
08:28am, Monday, 13'th Feb 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Globus And NuVasive Take Spinal Fusion To A New Level
05:11am, Sunday, 12'th Feb 2023
Globus and NuVasive agreed to merge in a deal that will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share (or $3.1B). Globus shares sold off sharply, as the Street cle
Globus Medical to Buy NuVasive in $3.1 Billion Deal
07:33am, Thursday, 09'th Feb 2023
The implied price for NuVasive under terms of the deal is $57.72 a share.
NuVasive rallies while Globus Medical moves down after companies announce all-stock merger deal
07:27am, Thursday, 09'th Feb 2023
Globus Medical GMED, -1.18% said Thursday it will pay 0.75 a share of its stock for each share of NuVasive NUVA, -2.41% stock in a deal that values NuVasive at about $3.1 billion or $57.72 a share. Gl
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
04:30pm, Thursday, 02'nd Feb 2023
AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year
